Xencor reported 717K in Interest Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Alnylam Pharmaceuticals ALNY:US 1.9M 887K
Arrowhead Research ARWR:US 1.24M 186K
Biogen BIIB:US 12.6M 9.7M
Cytokinetics CYTK:US 864K 449K
Karyopharm Therapeutics KPTI:US 293K 219K
Pfizer PFE:US 30M 16M
Xencor XNCR:US 717K 64K